Counterfeit medicine from Asia threatens lives in Africa | The Guardian
Though it may seem like an immense amount of trouble to counterfeit a £3 packet of malaria pills, Lulukay noted that the global trade was estimated at £46bn a year. Counterfeiters know their markets well and target medications accordingly. Efforts to combat the activity are in their infancy. (...) India has stepped up oversight, “China is only now just catching on”
China rejects claims of producing fake medicine for Africa | World news | guardian.co.uk
China has denied allegations that it has been exporting huge amounts of counterfeit medication to Africa, threatening public health in east Africa, five days after the Guardian published a front page exposé on the phenomenon.
The official Xinhua news agency said a foreign ministry spokeswoman rejected the accusation, but “called on foreign traders to procure medicines from legitimate companies through standardised channels”.
India rejects claims it exported fake medicine to Africa | World news | guardian.co.uk
India has denied claims that it has exported large quantities of counterfeit medication to Africa, after the Guardian published a front-page exposé on the phenomenon.
“No fake medicines have been sent from India to the continent of Africa,” a spokesman for the ministry of external affairs in Delhi said.
Israelis find possible cure for malaria
The body’s immune system sends antibodies to combat the disruptive proteins, but the Plasmodium parasite is able to use one type of protein to keep the antibodies busy while producing a different protein to continue the infection.
The Israeli researchers have unlocked the unique DNA sequence that allows the Plasmodium parasite to do this.
#Malaria programme gets kiss of death from #Global_Fund : Nature
The Global Fund’s press release detailing its plans is entitled “Board Approves Integration of AMF-m into Core Global Fund Grant Processes“, and much of its soothingly reassuring content would perhaps have many thinking that the AMF-m’s integration into the Global Fund’s core grants system is good news. But it is in effect being killed. There’s will be no new money ringfenced for the AMF-m once it runs through it’s current funding up to the end of 2013, which means that any countries wanting to set aside cash for the private sector will be required to take this from their country grants from the Global Fund. In reality, that will likely translate into AMF-m activities simply being terminated in most countries, leading to local price rises in ACTs, and the drugs disappearing off the shelves of local pharmacies. AMF-m’s clout in negotiating bulk pricing deals internationally will also likely be weakened.
WHO | Atlas of health and climate
The Atlas of health and climate is a product of this unique collaboration between the meteorological and public health communities. It provides sound scientific information on the connections between weather and climate and major health challenges. These range from diseases of poverty to emergencies arising from extreme weather events and disease outbreaks. They also include environmental degradation, the increasing prevalence of noncommunicable diseases and the universal trend of demographic ageing.
#santé #changement_climatique #rapport #cartographie #données #paludisme #malaria #choléra #sanitation #assainissement #eau #dengue #méningite #inondations #cyclones #sécheresse #feu #forêts #pollution #allergies
Le bon mobile du chasseur de moustiques | Nicolas Patte
Une étude universitaire a scruté une année entière de données personnelles de 15 millions de clients mobile au Kenya pour améliorer la lutte contre le #paludisme. Malgré des résultats encourageants et l’anonymisation des données, des questions de vie privée pourraient mettre un grain de sable dans le projet.
Tracking Malaria With Cell Phones - ABC News
Harvard researchers found they could track the spread of malaria in Kenya using phone calls and text messages from 15 million mobile phones.
“Before mobile phones, we had proxies for human travel, like road networks, census data and small-scale GPS studies,” said study author Caroline Buckee, an assistant professor of epidemiology at the Harvard School of Public Health. “But now that mobile phones have spread throughout the world, we can start using these massive amounts of data to quantify human movements on a larger scale and couple this data with knowledge of infection risk.” (...) By studying networks of human and parasite movement, the team could then determine primary sources of #malaria and who was most likely to become infected.
#Malaria returns to crisis-torn Greece - Telegraph
Malaria has returned to Greece as financial cuts contribute to the re-emergence of a once extinct disease.
#Nigeria: Artequick promises 24-hr treatment for #malaria, elimination in 20 years
Chinese researchers say with Artequick, a fixed-dose combination of artemisinin and piperaquine, malaria can be effectively treated within 24 hours and possibly eliminated from human population in 20 years.
New species poses greater #malaria threat - IOL
Scientists have discovered what could be a new type of mosquito in Africa with the potential to cause hundreds of thousands more deaths from malaria.
Is this the Holy Grail of #malaria cures? - IOL SciTech | IOL.co.za
Researchers at UCT are optimistic they have found a drug that can cure all strains of malaria with a single oral dose.
Some scientists have called the breakthrough drug discovery a gift to Africa, where malaria kills a million people every year.
In September 2010, a compound code named MMV390048, which subsequently displayed exceptional potency against the parasite, was first designed and made. The compound is stable, and showed significant promise in an in vitro experiment. It was tested in animals in early 2011. The resultant data was even more encouraging as MMV390048 displayed a complete cure of animals infected with malaria parasites when given orally (by mouth) at a low (20 mg/kg) dose. More importantly, the drug remained in the animal for a long time – preventing any potential regrowth of the parasite.
If the creeks don’t rise... #changement_climatique et #santé
on Monday afternoon:
– In Nigeria, floods kill 10, displace 20,000.
– Recurring droughts highlight need for better water management.
– DPR Korea: Malnutrition rate may increase following floods.
– Haiti: Isaac leaves 19 dead, 15,000 evacuated.
When I see a climate-related report now—drought, heavy rain, storms, floods—my heart sinks. What follows is going to be leptospirosis, #malaria, little children dead of diarrhea or #cholera or starvation, and dengue moving in clouds of Aedes aegypti mosquitoes.
In a renewed hope to eliminate the menace of malaria on human health, researchers at the Johns Hopkins Malaria Research Institute have genetically modified a bacterium commonly found in the mosquito’s midgut, to kill the malaria parasite before it is transmitted.
(...) According to a study published by PNAS, the modified bacteria were 98 percent effective (...).
Drug-resistant #malaria strain in Myanmar is global threat
The world must help Myanmar fight a drug-resistant strain of malaria that could kill up to 200,000 children a year if it reaches India and Africa, a veteran health worker in the Southeast Asian country has warned.
But Frank Smithuis, former head of medical charity Medecins Sans Frontieres (MSF) in Myanmar, said major donors had excluded the country from their anti-malaria programmes, seriously jeopardising a concerted international effort to contain the epidemic.
#Pharma backs latest attempt at a global health #R&D_treaty : Spoonful of Medicine
“Now that it’s about funding, governments have to start talking to each other.”
Importantly, big pharma appears to be on-board—which may pave the way for successful passage of the treaty at next week’s World Health Assembly. “We’re hearing from industry a need to reform the current system,” says CEWG chair John-Arne Røttingen, a health economist at the University of Oslo’s Institute for Health and Society who coauthored the report. Similar proposals were put forward by coalitions of member states and non-governmental organizations in 2005 and 2009, but both efforts failed to even make it to a vote after drug companies lobbied hard against proposed patent reforms that would have opened the door to more generics for a wide variety of medicines. In contrast, the current draft treaty only calls for less patent protection of treatments for diseases commonly found in the developing world, such as #malaria, #Chagas disease and #dengue fever.
In our market alone, about 20-30% of drugs are fake, it’s even much more when it comes to Malaria drugs.
pas sûr que la solution adoptée soit bonne (casser les prix serait sans doute bcp plus efficace) ; mais l’état des lieux est effrayant
Scientists have found new evidence that resistance to the front-line treatments for malaria is increasing.
They have confirmed that resistant strains of the malaria parasite on the border between Thailand and Burma, 500 miles (800km) away from previous sites.
Researchers say that the rise of resistance means the effort to eliminate malaria is “seriously compromised”.
Greece on the breadline: #HIV and #malaria make a comeback | World news | The Guardian
The incidence of HIV/Aids among intravenous drug users in central Athens soared by 1,250% in the first 10 months of 2011 compared with the same period the previous year, according to the head of Médecins sans Frontières Greece, while malaria is becoming endemic in the south for the first time since the rule of the colonels.
Reveka Papadopoulos said that following savage cuts to the national health service budget, including heavy job losses and a 40% reduction in funding for hospitals, Greek social services were “under very severe strain, if not in a state of breakdown. What we are seeing are very clear indicators of a system that cannot cope.”
#Malaria kills twice as many people as previously thought, research finds | Society | The Guardian
Malaria kills twice as many people every year as formerly believed, taking 1.2 million lives and causing the deaths not only of babies but also older children and adults, according to research that overturns decades of assumptions about one of the world’s most lethal diseases.
A new map of “the other” #malaria | Nature
The malarial parasite, #Plasmodium #vivax, is something of a forgotten step sister to the more prevalent, more deadly Plasmodium falciparum. Global and local programmes looking to eradicate malaria may need to pay it more attention
The precarity of the global 99% | New Statesman
The Global Fund has for years been one of the most important fronts in the battle to beat back HIV/Aids. It has helped put 3.2 million people on anti-retroviral therapy (ARVs). But it has been running on empty for a year now, since securing just $10 billion — half of what it hoped for — during a major funding replenishment a year ago. Some countries also recently cut their pledges owing to concerns about the way the Global Fund is operated.
Ten billion dollars sounds like peanuts in comparison to the bank bailouts we have gotten used to in recent years — it’s about the same amount that Goldman Sachs has cheerfully set aside in bonuses again this year.
Economic crisis hits health aid that has helped millions as donors cut back - The Globe and Mail
The global economic crisis has claimed a new victim: a $22-billion (U.S.) health fund that has saved millions of lives in Africa and other low-income regions during the past decade.
Wealthy donors in Europe and elsewhere are drastically cutting back on contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria. As a result, in an unprecedented step, the fund has announced that it is cancelling its next round of grants, despite strong protests from health activists.
Stephen Lewis, the former United Nations special envoy on AIDS in Africa, warned that the funding cancellation will cost thousands of lives. “It’s incredible that so many countries should default on their commitments at exactly the moment when we know what to do to defeat the pandemic,” he said. “I don’t know how the financial architects of this disaster sleep at night.”
Global Fund halts new funding until 2014
“Substantial budget challenges in some donor countries, compounded by low interest rates have significantly affected the resources available for new grant funding,” the fund said in a statement on 23 November.
It will still provide some funding to existing projects to keep them going over the next couple of years, but will award no new grants before 2014. The fund, a public-private partnership supported by around 150 donor countries, also announced that it would create a new general manager position, taking management responsibility away from executive director Michel Kazatchkine.